drugset / Trial / NCT04330677

Dissecting the Role of Estradiol in Mediating Gender-specific Anxiolytic and Prosocial Effects of Oxytocin

NCT04330677

Phase 1 Completed 487 enrolled University Hospital, Bonn
RandomizedFactorialDouble-blindBasic science

Summary

The study aims to examine a behavioral and neural framework for understanding the sex-specific effects of the neuropeptide oxytocin (OXT). Using hormonal, behavioral and neuroimaging readouts, it is planned to explore the interplay of OXT and estradiol as a potential mechanism mediating sexual dimorphic effects.

Timeline

Start
2016-09-18
Primary completion
2020-01-25
Completion
2020-01-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Estradiol Other / unclassified 2 mg Topical
Subject Oxytocin Peptide 24 iu Intranasal

Indications

No indication recorded.